Table 1.
Origin of the isolates of Sporothrix schenckii complex |
Origanum majorana L. (mg/mL) |
Itraconazole (μg/mL) |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
MIC |
MFC |
MIC |
MFC |
|||||||||
Range | 50% | 90% | Range | 50% | 90% | Range | 50% | 90% | Range | 50% | 90% | |
Sporothrix brasiliensis | ||||||||||||
Humans (n: 3) | ≤2.25–4.5 | – | – | ≤2.25–4.5 | – | – | ≤0.03–0.5 | – | – | ≤0.03 to 2 | – | – |
Dogs (n: 6) | ≤2.25–4.5 | ≤2.25 | ≤2.25 | ≤2.25–18 | 4.5 | 9 | 0.5–8 | 1 | 2 | 1 to >16 | 2 | 16 |
Cats (n: 8) | ≤2.25–9 | ≤2.25 | 4.5 | ≤2.25–9 | 4.5 | 9 | ≤0.03–16 | 2 | 16 | 0.25 to >16 | 2 | >16 |
Overall (n: 17) | ≤2.25–9 | ≤2.25 | 4.5 | ≤2.25–18 | 4.5 | 9 | ≤0.03–16 | 2 | 8 | ≤0.03 to >16 | 2 | >16 |
Sporothrix schenckii | ||||||||||||
IOC 1226 (n: 1) | ≤2.25 | – | – | ≤2.25 | – | – | 1 | – | – | 8 | – | – |
Overall (n: 18) | ≤2.25–9 | ≤2.25 | 4.5 | ≤2.25–18 | 4.5 | 9 | ≤0.03–16 | 1 | 16 | ≤0.03 to >16 | 2 | >16 |
50%, MIC/MFC at which 50% of isolates were inhibited/eliminated; 90%, MIC/MFC at which 90% of isolates were inhibited/eliminated.